Literature DB >> 8519983

Effects of cellular pharmacology on drug distribution in tissues.

R K Rippley1, C L Stokes.   

Abstract

The efficacy of targeted therapeutics such as immunotoxins is directly related to both the extent of distribution achievable and the degree of drug internalization by individual cells in the tissue of interest. The factors that influence the tissue distribution of such drugs include drug transport; receptor/drug binding; and cellular pharmacology, the processing and routing of the drug within cells. To examine the importance of cellular pharmacology, previously treated only superficially, we have developed a mathematical model for drug transport in tissues that includes drug and receptor internalization, recycling, and degradation, as well as drug diffusion in the extracellular space and binding to cell surface receptors. We have applied this "cellular pharmacology model" to a model drug/cell system, specifically, transferrin and the well-defined transferrin cycle in CHO cells. We compare simulation results to models with extracellular diffusion only or diffusion with binding to cell surface receptors and present a parameter sensitivity analysis. The comparison of models illustrates that inclusion of intracellular trafficking significantly increases the total transferrin concentration throughout much of the tissue while decreasing the penetration depth. Increasing receptor affinity or tissue receptor density reduces permeation of extracellular drug while increasing the peak value of the intracellular drug concentration, resulting in "internal trapping" of transferrin near the source; this could account for heterogeneity of drug distributions observed in experimental systems. Other results indicate that the degree of drug internalization is not predicted by the total drug profile. Hence, when intracellular drug is required for a therapeutic effect, the optimal treatment may not result from conditions that produce the maximal total drug distribution. Examination of models that include cellular pharmacology may help guide rational drug design and provide useful information for whole body pharmacokinetic studies.

Mesh:

Substances:

Year:  1995        PMID: 8519983      PMCID: PMC1236312          DOI: 10.1016/S0006-3495(95)79956-8

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  49 in total

1.  Comparisons between two monoclonal antibodies that bind to the same antigen but have differing affinities: uptake kinetics and 125I-antibody therapy efficacy in multicell spheroids.

Authors:  V K Langmuir; H L Mendonca; D V Woo
Journal:  Cancer Res       Date:  1992-09-01       Impact factor: 12.701

Review 2.  Immunotoxins--entry into cells and mechanisms of action.

Authors:  S Olsnes; K Sandvig; O W Petersen; B van Deurs
Journal:  Immunol Today       Date:  1989-09

3.  Intracellular routing rather than cross-linking or rate of internalization determines the potency of immunotoxins directed against different epitopes of sIgD on murine B cells.

Authors:  R D May; H T Wheeler; F D Finkelman; J W Uhr; E S Vitetta
Journal:  Cell Immunol       Date:  1991-07       Impact factor: 4.868

4.  Relationship between internalization and cytotoxicity of ricin A-chain immunotoxins.

Authors:  F W Preijers; W J Tax; T De Witte; A Janssen; H vd Heijden; H Vidal; J M Wessels; P J Capel
Journal:  Br J Haematol       Date:  1988-11       Impact factor: 6.998

5.  Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy.

Authors:  Y Boucher; L T Baxter; R K Jain
Journal:  Cancer Res       Date:  1990-08-01       Impact factor: 12.701

Review 6.  Immunotoxins: magic bullets or misguided missiles?

Authors:  E S Vitetta; P E Thorpe; J W Uhr
Journal:  Immunol Today       Date:  1993-06

7.  Penetration and binding of radiolabeled anti-carcinoembryonic antigen monoclonal antibodies and their antigen binding fragments in human colon multicellular tumor spheroids.

Authors:  R Sutherland; F Buchegger; M Schreyer; A Vacca; J P Mach
Journal:  Cancer Res       Date:  1987-03-15       Impact factor: 12.701

8.  Micropharmacology of monoclonal antibodies in solid tumors: direct experimental evidence for a binding site barrier.

Authors:  M Juweid; R Neumann; C Paik; M J Perez-Bacete; J Sato; W van Osdol; J N Weinstein
Journal:  Cancer Res       Date:  1992-10-01       Impact factor: 12.701

9.  An analysis of monoclonal antibody distribution in microscopic tumor nodules: consequences of a "binding site barrier".

Authors:  W van Osdol; K Fujimori; J N Weinstein
Journal:  Cancer Res       Date:  1991-09-15       Impact factor: 12.701

10.  Inhibition of leukemia cell proliferation by receptor-mediated uptake of c-myb antisense oligodeoxynucleotides.

Authors:  G Citro; D Perrotti; C Cucco; I D'Agnano; A Sacchi; G Zupi; B Calabretta
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

View more
  7 in total

1.  Monitoring therapeutic monoclonal antibodies in brain tumor.

Authors:  Rima Ait-Belkacem; Caroline Berenguer; Claude Villard; L'Houcine Ouafik; Dominique Figarella-Branger; Alain Beck; Olivier Chinot; Daniel Lafitte
Journal:  MAbs       Date:  2014       Impact factor: 5.857

2.  Identification of key processes that control tumor necrosis factor availability in a tuberculosis granuloma.

Authors:  Mohammad Fallahi-Sichani; Matthew A Schaller; Denise E Kirschner; Steven L Kunkel; Jennifer J Linderman
Journal:  PLoS Comput Biol       Date:  2010-05-06       Impact factor: 4.475

Review 3.  Antibody tumor penetration: transport opposed by systemic and antigen-mediated clearance.

Authors:  Greg M Thurber; Michael M Schmidt; K Dane Wittrup
Journal:  Adv Drug Deliv Rev       Date:  2008-04-24       Impact factor: 15.470

4.  Mathematical and computational models of drug transport in tumours.

Authors:  C M Groh; M E Hubbard; P F Jones; P M Loadman; N Periasamy; B D Sleeman; S W Smye; C J Twelves; R M Phillips
Journal:  J R Soc Interface       Date:  2014-03-12       Impact factor: 4.118

5.  High-resolution mapping of fluoroquinolones in TB rabbit lesions reveals specific distribution in immune cell types.

Authors:  Landry Blanc; Isaac B Daudelin; Brendan K Podell; Pei-Yu Chen; Matthew Zimmerman; Amanda J Martinot; Rada M Savic; Brendan Prideaux; Véronique Dartois
Journal:  Elife       Date:  2018-11-14       Impact factor: 8.140

Review 6.  Current advances in mathematical modeling of anti-cancer drug penetration into tumor tissues.

Authors:  Munju Kim; Robert J Gillies; Katarzyna A Rejniak
Journal:  Front Oncol       Date:  2013-11-18       Impact factor: 6.244

7.  Thermosensitive Liposome-Mediated Drug Delivery in Chemotherapy: Mathematical Modelling for Spatio-temporal Drug Distribution and Model-Based Optimisation.

Authors:  Yu Huang; Boram Gu; Cong Liu; Justin Stebbing; Wladyslaw Gedroyc; Maya Thanou; Xiao Yun Xu
Journal:  Pharmaceutics       Date:  2019-11-29       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.